A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients

CONCLUSIONS: The immunogenicity of PPV23 and PCV13 was comparable in this patient material, but the seroresponses waned after transplantation. The second dose of PCV13 restored the immune responses and was well tolerated.PMID:33812743 | DOI:10.1016/j.vaccine.2021.03.063

Source: Vaccine - April 4, 2021 Category: Allergy & Immunology Authors: Mari Eriksson Helena K äyhty Mika Lahdenkari Heikki M äkisalo Veli-Jukka Anttila Source Type: research